Driving cancer evolution.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28282287.
- Also identified by DOI 10.7554/eLife.25431 and PMC identifier 5345930.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Tumor-growth-factor-beta signaling helps cancer cells to evolve and become resistant to drugs by down-regulating accurate DNA repair.
Medical subject headings
- Neoplasms
- Transforming Growth Factor beta